Clinical Trials Logo

Clinical Trial Summary

The clinical practice recommendations highlight the fact that the patient's choice concerning the management of her aborted pregnancy in the first trimester should be privileged, after clear and appropriate information on the available treatments, in order to improve his experience and reduce the negative psychological symptoms that can generate an alteration in the quality of life, in the aftermath of the loss of pregnancy. The present study will describe the efficacy, satisfaction and tolerance of patients benefiting from medical treatment with Mifégyne® and MisoOne® versus those benefiting from surgical treatment by endo-uterine aspiration for the management of a pregnancy stopped during the first trimester at the Toulouse University Hospital


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05049980
Study type Interventional
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date November 1, 2021
Completion date February 14, 2022

See also
  Status Clinical Trial Phase
Completed NCT04549909 - Biochemical Pregnancy Loss. A Multicenter Retrospective Study